New Zealand draft recreational cannabis legislation released

New Zealand draft recreational cannabis legislation released

New Zealand draft recreational cannabis legislation released Whether you like it or not, having both medical and non-medical cannabis frameworks in place means there will be interaction between the two. Despite the qualitative differences between medical and non-medical products, services, regulations and patients/consumers, the legalisation of non-medical cannabis impacts medical users.  FreshLeaf Analytics and the...
Read More
governments public health data

As medical cannabis access gets easier, governments will miss out on public health data

As medical cannabis access gets easier, governments will miss out on public health data Recent reforms at the State level in NSW and QLD mean increasing patient numbers will be traded off against quality data collection. This is good for patients but will make it harder for governments and industry to track market expansion. A...
Read More
ANTG second Australian company

ANTG second Australian company to bring domestically cultivated products to market

ANTG second Australian company to bring domestically cultivated products to market   ANTG, a NSW-based medicinal cannabis company, has announced that their first product is ready for Australian patients.  The news, published on the company’s website, highlighted the registration of the product as an export-only medicine, listed on the Australian Register of Therapeutic Goods (ARTG)....
Read More
AustraliaSenate inquiry

Australia launches Senate inquiry into medical cannabis patient access

Australia launches Senate inquiry into medical cannabis patient access The Australian Senate has just launched an inquiry into patient access to medical cannabis. The matter was referred by the leader of the Greens, Senator Di Natale, to the Community Affairs References Committee. The Committee is now required to report on the matter before February 12th,...
Read More
Freshleaf Analytics - Upcoming changes

ODC consults with industry on upcoming changes to licenses and more

ODC consults with industry on upcoming changes to licenses and more   The ODC has a lot on it’s plate right now – re-configuring their operational structure, dealing with the influx of new applicants, managing existing license holders, and planning for the implementation of the 26 recommendations that came out of the McMillan review. This...
Read More
Patient access to medical cannabis in Western Australia

Patient access to medical cannabis in Western Australia set to improve

Patient access to medical cannabis in Western Australia set to improve   We wrote recently about how empowering GP prescribers in QLD is partly responsible for the disproportionate levels of SAS-B approvals in that State. And how NSW would be the next to follow suit, having made similar changes to their State approval system.   ...
Read More

Patient access to medical cannabis – October figures released

Patient access to medical cannabis October figures released by Rhys Cohen 1. Record growth continues Another record month for medicinal cannabis approvals in Australia via the Special Access Scheme Category B route! 3,594 approvals were issued in October 2019. It’s worth remembering how far the Australian market has come in just the last 12 months....
Read More
Q3 report 2019 - FreshLeaf Analytics Medicinal Cannabis Patient, Product and Pricing Analysis released

Medicinal Cannabis Patient, Product and Pricing Analysis released

Australia’s Most Comprehensive Medicinal Cannabis Patient, Product and Pricing Analysis released FreshLeaf Analytics has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis. The study was conducted in Q3 2019 and includes insights into the pricing and availability of legal medicinal cannabis products in the Australian marketplace including: Number of products in market...
Read More
First Australian Medicinal Cannabis Product hits the market

First Australian Medicinal Cannabis Product hits the market

The last 2 years have seen a huge amount of speculation in Australia around medicinal cannabis stocks. A number of companies have listed on the ASX, raising substantial amounts of capital and seeing their market caps rise to astronomical levels. Auscann, one of the early movers in the medicinal cannabis game that traces its roots...
Read More
P high-cost medical cannabis in Australia

The myth of high-cost medical cannabis in Australia

Australian media has in recent years reported on the high costs of medicinal cannabis (also known as medicinal marijuana), quoting numbers as high as $40K per year for patient treatment. But does it actually cost this much? In most cases the numbers quoted are referencing patients with epilepsy who are taking extremely high dosages. Numerous...
Read More
1 2 3 4